Age and CIRS-G for risk stratification in elderly esophageal squamous cell carcinoma patients receiving definitive chemoradiotherapy
Frontiers in Oncology · 20.08.2026 · 16
DOI: 10.3389/fonc.2026.1898060 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Oncology, online erschienen am 20.08.2026. Verfasst von Mingyu Li und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Therapy, The Second Affiliated Hospital of Xingtai Medical College, Xingtai, China. Die Arbeit nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Objective
To identify prognostic factors in elderly squamous cell carcinoma (ESCC) patients receiving definitive chemoradiotherapy (dCRT) and construct a prognostic risk stratification model for identifying high-risk subgroups among elderly patients.
Methods
ESCC patients aged ≥ge years receiving dCRT were enrolled. Baseline Cumulative Illness Rating Scale-Geriatrics (CIRS-G), Geriatric Nutrition Risk Index (GNRI), Systemic Immune-Inflammation Index (SII), clinical characteristics and adverse events were collected. Cox regression identified independent prognostic factors, with proportional hazards assessed by Schoenfeld residual tests and 95% confidence intervals validated by 1000 bootstrap resamples. Restricted cubic spline (RCS) curves evaluated potential cutoff values. Survival was analyzed by Kaplan-Meier method and compared by log-rank test.
Results
88 patients were enrolled. Multivariate analysis identified age (HR 1.047, 95% CI 1.000–1.095) and CIRS-G (HR 1.179, 95% CI 1.014–1.376) as independent predictors of OS, whereas GNRI (HR 0.964, 95% CI 0.932–0.995) independently predicted PFS. Schoenfeld tests confirmed proportional hazards (all P > 0.05), with bootstrap resampling supporting coefficient stability. Cutoffs were set at 75 years for age, 7 for CIRS-G, and 98 for GNRI. A prognostic score combining age and CIRS-G stratified patients into low-risk (0–1) and high-risk (2) groups, with high-risk patients showing significantly inferior OS. GNRI ≥98 correlated with prolonged PFS versus <98. The high-risk group had higher neutropenia/leukopenia (15.0% vs. 6.3%) and pneumonitis (5.0% vs. 2.1%), with exclusive thrombocytopenia/anemia (2.5% each).
Conclusions
A composite risk score (age ≥75 years plus CIRS-G ≥7) identified a high-risk subgroup with poor OS. The optimal therapeutic strategy for this subgroup warrants prospective interventional trials.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Radiation Therapy, The Second Affiliated Hospital of Xingtai Medical College, Xingtai, China.
Zitieren
APA
Li, M., Zhang, B., Hao, J., Song, G., Zhang, M., Hao, Y., Zhao, L., Wu, Y., Lu, F., & Zhang, Q. (2026). Age and CIRS-G for risk stratification in elderly esophageal squamous cell carcinoma patients receiving definitive chemoradiotherapy. Frontiers in Oncology, 16. https://doi.org/10.3389/fonc.2026.1898060
Vancouver
Li M, Zhang B, Hao J, Song G, Zhang M, Hao Y, et al. Age and CIRS-G for risk stratification in elderly esophageal squamous cell carcinoma patients receiving definitive chemoradiotherapy. Frontiers in Oncology. 2026;16. doi:10.3389/fonc.2026.1898060
BibTeX
@article{Li2026,
author = {Li, Mingyu and Zhang, Bo and Hao, Jianping and Song, Guoming and Zhang, Ming and Hao, Yunran and Zhao, Lijun and Wu, Yayuan and Lu, Fangming and Zhang, Qian},
title = {Age and CIRS-G for risk stratification in elderly esophageal squamous cell carcinoma patients receiving definitive chemoradiotherapy},
journal = {Frontiers in Oncology},
year = {2026},
volume = {16},
doi = {10.3389/fonc.2026.1898060}
}
EUVIMED